Advertisement
UK markets close in 5 hours 48 minutes
  • FTSE 100

    8,110.09
    +31.23 (+0.39%)
     
  • FTSE 250

    19,837.90
    +235.92 (+1.20%)
     
  • AIM

    755.73
    +2.61 (+0.35%)
     
  • GBP/EUR

    1.1657
    +0.0000 (+0.00%)
     
  • GBP/USD

    1.2514
    +0.0003 (+0.03%)
     
  • Bitcoin GBP

    51,541.95
    +456.96 (+0.89%)
     
  • CMC Crypto 200

    1,391.10
    -5.44 (-0.39%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    83.81
    +0.24 (+0.29%)
     
  • GOLD FUTURES

    2,361.30
    +18.80 (+0.80%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,038.11
    +120.83 (+0.67%)
     
  • CAC 40

    8,029.62
    +12.97 (+0.16%)
     

Analysts’ Recommendations for Edwards Lifesciences before 3Q17

As of October 13, 2017, according to a Reuters survey consisting of 22 brokerage firms, 77.3% of the firms rated Edwards Lifesciences a "buy.”